Literature DB >> 20072802

A new approach to the compartmental analysis in pharmacokinetics: fractional time evolution of diclofenac.

Jovan K Popović1, Milica T Atanacković, Ana S Pilipović, Milan R Rapaić, Stevan Pilipović, Teodor M Atanacković.   

Abstract

This study presents a new two compartmental model and its application to the evaluation of diclofenac pharmacokinetics in a small number of healthy adults, during a bioequivalence trial. In the model the integer order derivatives are replaced by derivatives of real order often called fractional order derivatives. Physically that means that a history (memory) of a biological process, realized as a transfer from one compartment to another one with the mass balance conservation, is taken into account. This kind of investigations in pharmacokinetics is founded by Dokoumetzidis and Macheras through the one compartmental models while our contribution is the analysis of multi-dimensional compartmental models with the applications of the two compartmental model in evaluation of diclofenac pharmacokinetics. Two experiments were preformed with 12 healthy volunteers with two slow release 100 mg diclofenac tablet formulations. The agreement of the values predicted by the proposed model with the values obtained through experiments is shown to be good. Thus, pharmacokinetics of slow release diclofenac can be described well by a specific two compartmental model with fractional derivatives of the same order. Parameters in the model are determined by the least-squares method and the Particle Swarm Optimization (PSO) numerical procedure is used. The results show that the fractional order two compartmental model for diclofenac is superior in comparison to the classical two compartmental model. Actually this is true in general case since the classical one is a special case of the fractional one.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20072802     DOI: 10.1007/s10928-009-9147-3

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  21 in total

1.  Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradil pharmacokinetics.

Authors:  Kosmas Kosmidis; Vangelis Karalis; Panos Argyrakis; Panos Macheras
Journal:  Biophys J       Date:  2004-09       Impact factor: 4.033

Review 2.  New mathematical methods in pharmacokinetic modeling.

Authors:  Mária Durisová; Ladislav Dedík
Journal:  Basic Clin Pharmacol Toxicol       Date:  2005-05       Impact factor: 4.080

3.  Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.

Authors:  J Popović; R Mitić; A Sabo; M Mikov; V Jakovljević; K Daković-Svajcer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Apr-Jun       Impact factor: 2.441

4.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system.

Authors:  Aristides Dokoumetzidis; Panos Macheras
Journal:  Int J Pharm       Date:  2006-07-15       Impact factor: 5.875

5.  Fractal reaction kinetics.

Authors:  R Kopelman
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

6.  Carrier-mediated transport can obey fractal kinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 7.  Noncompartmental models of whole-body clearance of tracers: a review.

Authors:  K H Norwich
Journal:  Ann Biomed Eng       Date:  1997 May-Jun       Impact factor: 3.934

8.  High-performance liquid chromatographic determination of diclofenac and its monohydroxylated metabolites in biological fluids.

Authors:  J Godbillon; S Gauron; J P Metayer
Journal:  J Chromatogr       Date:  1985-02-27

9.  A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics.

Authors:  P Macheras
Journal:  Pharm Res       Date:  1996-05       Impact factor: 4.200

10.  Fractal michaelis-menten kinetics under steady state conditions: Application to mibefradil.

Authors:  Rebeccah E Marsh; Jack A Tuszyński
Journal:  Pharm Res       Date:  2006-10-25       Impact factor: 4.580

View more
  10 in total

1.  Fractional dynamics pharmacokinetics-pharmacodynamic models.

Authors:  Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-05-09       Impact factor: 2.745

2.  A commentary on fractionalization of multi-compartmental models.

Authors:  Aristides Dokoumetzidis; Richard Magin; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-10       Impact factor: 2.745

3.  Fractional kinetics in multi-compartmental systems.

Authors:  Aristides Dokoumetzidis; Richard Magin; Panos Macheras
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-10-01       Impact factor: 2.745

4.  Individualization of a pharmacokinetic model by fractional and nonlinear fit improvement.

Authors:  Jovan K Popović; Mihalj Poša; Kosta J Popović; Dušica J Popović; Nataša Milošević; Vesna Tepavčević
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-05-23       Impact factor: 2.441

5.  How to avoid unbounded drug accumulation with fractional pharmacokinetics.

Authors:  Maud Hennion; Emmanuel Hanert
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12       Impact factor: 2.745

6.  Fractional calculus in pharmacokinetics.

Authors:  Pantelis Sopasakis; Haralambos Sarimveis; Panos Macheras; Aristides Dokoumetzidis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-10-03       Impact factor: 2.745

7.  A nonlinear two compartmental fractional derivative model.

Authors:  Jovan K Popović; Diana Dolićanin; Milan R Rapaić; Stevan L Popović; Stevan Pilipović; Teodor M Atanacković
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-07-30       Impact factor: 2.441

8.  Simulation of Drug Uptake in a Two Compartmental Fractional Model for a Biological System.

Authors:  Ivo Petráš; Richard L Magin
Journal:  Commun Nonlinear Sci Numer Simul       Date:  2011-12       Impact factor: 4.260

9.  Comparison of the gamma-Pareto convolution with conventional methods of characterising metformin pharmacokinetics in dogs.

Authors:  Carl A Wesolowski; Surajith N Wanasundara; Paul S Babyn; Jane Alcorn
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-12-21       Impact factor: 2.745

10.  Fractional model for the spread of COVID-19 subject to government intervention and public perception.

Authors:  K M Furati; I O Sarumi; A Q M Khaliq
Journal:  Appl Math Model       Date:  2021-02-17       Impact factor: 5.129

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.